| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | serine-type peptidase activity | 1.59e-07 | 207 | 81 | 9 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 1.95e-07 | 212 | 81 | 9 | GO:0017171 | |
| GeneOntologyMolecularFunction | calcium ion binding | BMP1 FAT2 DSC2 DSC3 MATN3 FSTL5 PCDHB5 PCDHB12 CAPNS2 UMOD LTBP2 EML1 SMOC1 EFCAB7 RYR2 | 2.89e-07 | 749 | 81 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 1.03e-06 | 190 | 81 | 8 | GO:0004252 | |
| GeneOntologyMolecularFunction | peptidase activity | DPP7 PCSK5 TPP2 DPEP1 BMP1 HPR LPA PEPD CAPNS2 CASP6 MMP2 PLG CFB | 2.15e-06 | 654 | 81 | 13 | GO:0008233 |
| GeneOntologyMolecularFunction | endopeptidase activity | 9.28e-06 | 430 | 81 | 10 | GO:0004175 | |
| GeneOntologyMolecularFunction | aminopeptidase activity | 7.06e-04 | 43 | 81 | 3 | GO:0004177 | |
| GeneOntologyMolecularFunction | serine-type exopeptidase activity | 1.04e-03 | 12 | 81 | 2 | GO:0070008 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 1.05e-03 | 110 | 81 | 4 | GO:0008238 | |
| GeneOntologyBiologicalProcess | renal urate salt excretion | 4.23e-05 | 3 | 78 | 2 | GO:0097744 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CFH FAT2 SRPX2 ABL2 DSC2 CCM2L DSC3 HLA-DRB5 PCDHB5 PCDHB12 UMOD PLG CTNND2 LILRB1 | 4.60e-05 | 1077 | 78 | 14 | GO:0098609 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 8.89e-05 | 377 | 78 | 8 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 9.06e-05 | 378 | 78 | 8 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 9.22e-05 | 379 | 78 | 8 | GO:0045229 | |
| GeneOntologyBiologicalProcess | positive regulation of fibrinolysis | 1.40e-04 | 5 | 78 | 2 | GO:0051919 | |
| GeneOntologyBiologicalProcess | learning | 1.52e-04 | 212 | 78 | 6 | GO:0007612 | |
| GeneOntologyCellularComponent | cell surface | CFH SRPX2 FCRL3 ARSB LPA HLA-DRB5 ROR1 CNTNAP2 UMOD ABCG2 GRIN2A PLG OCLN LILRB1 IGSF3 | 1.52e-05 | 1111 | 79 | 15 | GO:0009986 |
| GeneOntologyCellularComponent | side of membrane | CFH DPEP1 PTPN4 FCRL3 LPA HLA-DRB5 UMOD ABCG2 PLG EFCAB7 LILRB1 RYR2 | 1.04e-04 | 875 | 79 | 12 | GO:0098552 |
| GeneOntologyCellularComponent | extracellular matrix | 1.77e-04 | 656 | 79 | 10 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.82e-04 | 658 | 79 | 10 | GO:0030312 | |
| MousePheno | abnormal conjunctival epithelium morphology | 3.47e-06 | 7 | 66 | 3 | MP:0004481 | |
| MousePheno | abnormal kidney thrombosis | 1.18e-05 | 10 | 66 | 3 | MP:0011507 | |
| MousePheno | abnormal mammary gland connective tissue morphology | 2.20e-05 | 2 | 66 | 2 | MP:0009507 | |
| MousePheno | ectropion | 2.20e-05 | 2 | 66 | 2 | MP:0006164 | |
| MousePheno | esophageal ulcer | 2.20e-05 | 2 | 66 | 2 | MP:0004547 | |
| MousePheno | duodenal ulcer | 2.20e-05 | 2 | 66 | 2 | MP:0003273 | |
| MousePheno | perianal ulcer | 2.20e-05 | 2 | 66 | 2 | MP:0005035 | |
| MousePheno | abnormal conjunctiva morphology | 2.78e-05 | 13 | 66 | 3 | MP:0001310 | |
| MousePheno | abnormal anus morphology | 2.78e-05 | 13 | 66 | 3 | MP:0005034 | |
| MousePheno | increased hepatocyte proliferation | 6.52e-05 | 17 | 66 | 3 | MP:0003893 | |
| MousePheno | absent cornea epithelium | 6.57e-05 | 3 | 66 | 2 | MP:0020856 | |
| MousePheno | increased circulating fibrinogen level | 1.31e-04 | 4 | 66 | 2 | MP:0012331 | |
| MousePheno | proctitis | 1.31e-04 | 4 | 66 | 2 | MP:0003305 | |
| MousePheno | abnormal uvea morphology | 1.36e-04 | 241 | 66 | 7 | MP:0005197 | |
| MousePheno | decreased tumor growth/size | 2.33e-04 | 64 | 66 | 4 | MP:0003447 | |
| MousePheno | abnormal esophagus morphology | 2.62e-04 | 66 | 66 | 4 | MP:0000467 | |
| MousePheno | abnormal anal canal morphology | 2.71e-04 | 27 | 66 | 3 | MP:0009053 | |
| MousePheno | abnormal ocular surface morphology | 2.78e-04 | 67 | 66 | 4 | MP:0013754 | |
| MousePheno | gastric ulcer | 3.25e-04 | 6 | 66 | 2 | MP:0003282 | |
| MousePheno | increased acute phase protein level | 4.54e-04 | 7 | 66 | 2 | MP:0014499 | |
| MousePheno | venoocclusion | 4.54e-04 | 7 | 66 | 2 | MP:0006137 | |
| MousePheno | peptic ulcer | 4.54e-04 | 7 | 66 | 2 | MP:0003301 | |
| MousePheno | abnormal stomach mucosa morphology | 4.73e-04 | 77 | 66 | 4 | MP:0010792 | |
| MousePheno | abnormal stomach wall morphology | 5.48e-04 | 80 | 66 | 4 | MP:0010783 | |
| MousePheno | abnormal trachea morphology | 5.74e-04 | 81 | 66 | 4 | MP:0002282 | |
| MousePheno | abnormal anterior eye segment morphology | CFH CRYGD ARSB DSC2 LPA PEPD CASP6 LTBP2 ABCG2 MMP2 PLG SMOC1 MUC5AC EDDM3A | 6.01e-04 | 1117 | 66 | 14 | MP:0005193 |
| MousePheno | abnormal circulating fibrinogen level | 6.04e-04 | 8 | 66 | 2 | MP:0010213 | |
| MousePheno | decreased keratinocyte migration | 6.04e-04 | 8 | 66 | 2 | MP:0012194 | |
| MousePheno | increased urine uric acid level | 6.04e-04 | 8 | 66 | 2 | MP:0009810 | |
| MousePheno | absent fibula | 6.04e-04 | 8 | 66 | 2 | MP:0005430 | |
| MousePheno | decreased susceptibility to neuronal excitotoxicity | 6.96e-04 | 37 | 66 | 3 | MP:0008236 | |
| MousePheno | increased stomach mucosa thickness | 7.74e-04 | 9 | 66 | 2 | MP:0005211 | |
| MousePheno | abnormal eyelid morphology | 7.93e-04 | 233 | 66 | 6 | MP:0001340 | |
| MousePheno | decreased susceptibility to induced choroidal neovascularization | 9.64e-04 | 10 | 66 | 2 | MP:0003434 | |
| MousePheno | decreased circulating phosphate level | 9.65e-04 | 93 | 66 | 4 | MP:0000198 | |
| MousePheno | decreased phosphate level | 1.00e-03 | 94 | 66 | 4 | MP:0014546 | |
| MousePheno | abnormal cornea epithelium morphology | 1.01e-03 | 42 | 66 | 3 | MP:0006000 | |
| MousePheno | abnormal rectum morphology | 1.08e-03 | 43 | 66 | 3 | MP:0000492 | |
| MousePheno | abnormal stomach morphology | 1.10e-03 | 248 | 66 | 6 | MP:0000470 | |
| MousePheno | stomach mucosa hyperplasia | 1.17e-03 | 11 | 66 | 2 | MP:0010799 | |
| MousePheno | abnormal keratinocyte migration | 1.17e-03 | 11 | 66 | 2 | MP:0012192 | |
| Domain | EGF | PCSK5 BMP1 CNTNAP3B FAT2 FCGBP MATN3 CNTNAP2 CNTNAP3 UMOD LTBP2 | 4.89e-08 | 235 | 78 | 10 | SM00181 |
| Domain | EGF-like_dom | PCSK5 BMP1 CNTNAP3B FAT2 FCGBP MATN3 CNTNAP2 CNTNAP3 UMOD LTBP2 | 8.42e-08 | 249 | 78 | 10 | IPR000742 |
| Domain | SUSHI | 1.20e-07 | 56 | 78 | 6 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.34e-07 | 57 | 78 | 6 | IPR000436 | |
| Domain | EGF | 9.55e-07 | 126 | 78 | 7 | PF00008 | |
| Domain | Sushi | 2.49e-06 | 52 | 78 | 5 | PF00084 | |
| Domain | CCP | 3.01e-06 | 54 | 78 | 5 | SM00032 | |
| Domain | EGF_3 | 6.13e-06 | 235 | 78 | 8 | PS50026 | |
| Domain | Kringle-like | 9.26e-06 | 32 | 78 | 4 | IPR013806 | |
| Domain | EGF_2 | 1.47e-05 | 265 | 78 | 8 | PS01186 | |
| Domain | LAM_G_DOMAIN | 1.87e-05 | 38 | 78 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 2.29e-05 | 40 | 78 | 4 | PF02210 | |
| Domain | LamG | 3.37e-05 | 44 | 78 | 4 | SM00282 | |
| Domain | Kringle | 4.57e-05 | 17 | 78 | 3 | IPR000001 | |
| Domain | Kringle_CS | 4.57e-05 | 17 | 78 | 3 | IPR018056 | |
| Domain | KRINGLE_2 | 4.57e-05 | 17 | 78 | 3 | PS50070 | |
| Domain | Kringle | 4.57e-05 | 17 | 78 | 3 | PF00051 | |
| Domain | KRINGLE_1 | 4.57e-05 | 17 | 78 | 3 | PS00021 | |
| Domain | KR | 4.57e-05 | 17 | 78 | 3 | SM00130 | |
| Domain | FA58C | 8.83e-05 | 21 | 78 | 3 | SM00231 | |
| Domain | FA58C_3 | 8.83e-05 | 21 | 78 | 3 | PS50022 | |
| Domain | FA58C_1 | 8.83e-05 | 21 | 78 | 3 | PS01285 | |
| Domain | FA58C_2 | 8.83e-05 | 21 | 78 | 3 | PS01286 | |
| Domain | Cadherin_CS | 9.29e-05 | 109 | 78 | 5 | IPR020894 | |
| Domain | EGF_1 | 9.43e-05 | 255 | 78 | 7 | PS00022 | |
| Domain | Laminin_G | 1.01e-04 | 58 | 78 | 4 | IPR001791 | |
| Domain | EGF-like_CS | 1.09e-04 | 261 | 78 | 7 | IPR013032 | |
| Domain | CADHERIN_1 | 1.10e-04 | 113 | 78 | 5 | PS00232 | |
| Domain | Cadherin | 1.10e-04 | 113 | 78 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 1.15e-04 | 114 | 78 | 5 | PS50268 | |
| Domain | - | 1.15e-04 | 114 | 78 | 5 | 2.60.40.60 | |
| Domain | CA | 1.20e-04 | 115 | 78 | 5 | SM00112 | |
| Domain | Cadherin-like | 1.25e-04 | 116 | 78 | 5 | IPR015919 | |
| Domain | F5_F8_type_C | 1.33e-04 | 24 | 78 | 3 | PF00754 | |
| Domain | FA58C | 1.33e-04 | 24 | 78 | 3 | IPR000421 | |
| Domain | Cadherin | 1.35e-04 | 118 | 78 | 5 | IPR002126 | |
| Domain | EGF_CA | 1.58e-04 | 122 | 78 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.70e-04 | 124 | 78 | 5 | IPR001881 | |
| Domain | VPS10 | 1.71e-04 | 5 | 78 | 2 | SM00602 | |
| Domain | Sortilin_C | 1.71e-04 | 5 | 78 | 2 | PF15901 | |
| Domain | Sortilin-Vps10 | 1.71e-04 | 5 | 78 | 2 | PF15902 | |
| Domain | VPS10 | 1.71e-04 | 5 | 78 | 2 | IPR006581 | |
| Domain | Sortilin_N | 1.71e-04 | 5 | 78 | 2 | IPR031778 | |
| Domain | Sortilin_C | 1.71e-04 | 5 | 78 | 2 | IPR031777 | |
| Domain | FIBRINOGEN_C_1 | 3.19e-04 | 32 | 78 | 3 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 3.19e-04 | 32 | 78 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 3.19e-04 | 32 | 78 | 3 | PS51406 | |
| Domain | PKD | 3.57e-04 | 7 | 78 | 2 | PF00801 | |
| Domain | Desmosomal_cadherin | 3.57e-04 | 7 | 78 | 2 | IPR009122 | |
| Domain | Cadherin_pro | 3.57e-04 | 7 | 78 | 2 | PF08758 | |
| Domain | Hirudin/antistatin | 3.57e-04 | 7 | 78 | 2 | IPR011061 | |
| Domain | IGc2 | 4.49e-04 | 235 | 78 | 6 | SM00408 | |
| Domain | Ig_sub2 | 4.49e-04 | 235 | 78 | 6 | IPR003598 | |
| Domain | EGF_CA | 4.61e-04 | 86 | 78 | 4 | PF07645 | |
| Domain | Cadherin_pro_dom | 4.74e-04 | 8 | 78 | 2 | IPR014868 | |
| Domain | Cadherin_pro | 4.74e-04 | 8 | 78 | 2 | SM01055 | |
| Domain | Growth_fac_rcpt_ | 4.93e-04 | 156 | 78 | 5 | IPR009030 | |
| Domain | Peptidase_S8_His-AS | 6.08e-04 | 9 | 78 | 2 | IPR022398 | |
| Domain | Peptidase_S8_Ser-AS | 6.08e-04 | 9 | 78 | 2 | IPR023828 | |
| Domain | Sialidases | 6.08e-04 | 9 | 78 | 2 | IPR011040 | |
| Domain | Galactose-bd-like | 6.46e-04 | 94 | 78 | 4 | IPR008979 | |
| Domain | Peptidase_S8_subtilisin-rel | 7.58e-04 | 10 | 78 | 2 | IPR015500 | |
| Domain | SUBTILASE_ASP | 7.58e-04 | 10 | 78 | 2 | PS00136 | |
| Domain | SUBTILASE_HIS | 7.58e-04 | 10 | 78 | 2 | PS00137 | |
| Domain | SUBTILASE_SER | 7.58e-04 | 10 | 78 | 2 | PS00138 | |
| Domain | - | 9.24e-04 | 11 | 78 | 2 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 9.24e-04 | 11 | 78 | 2 | IPR000209 | |
| Domain | PKD | 9.24e-04 | 11 | 78 | 2 | PS50093 | |
| Domain | PKD_dom | 9.24e-04 | 11 | 78 | 2 | IPR000601 | |
| Domain | Peptidase_S8 | 9.24e-04 | 11 | 78 | 2 | PF00082 | |
| Domain | - | 9.24e-04 | 11 | 78 | 2 | 2.60.40.670 | |
| Domain | TIL | 1.11e-03 | 12 | 78 | 2 | PF01826 | |
| Domain | C8 | 1.11e-03 | 12 | 78 | 2 | PF08742 | |
| Domain | CUB | 1.12e-03 | 49 | 78 | 3 | PF00431 | |
| Domain | CUB | 1.19e-03 | 50 | 78 | 3 | SM00042 | |
| Domain | Peptidase_S1A | 1.28e-03 | 113 | 78 | 4 | IPR001314 | |
| Domain | Unchr_dom_Cys-rich | 1.30e-03 | 13 | 78 | 2 | IPR014853 | |
| Domain | C8 | 1.30e-03 | 13 | 78 | 2 | SM00832 | |
| Domain | - | 1.34e-03 | 52 | 78 | 3 | 2.60.120.290 | |
| Domain | TRYPSIN_DOM | 1.37e-03 | 115 | 78 | 4 | PS50240 | |
| Domain | CUB | 1.41e-03 | 53 | 78 | 3 | PS01180 | |
| Domain | Quinoprotein_ADH-like_supfam | 1.41e-03 | 53 | 78 | 3 | IPR011047 | |
| Domain | Tryp_SPc | 1.46e-03 | 117 | 78 | 4 | SM00020 | |
| Domain | TIL_dom | 1.52e-03 | 14 | 78 | 2 | IPR002919 | |
| Domain | Trypsin | 1.65e-03 | 121 | 78 | 4 | PF00089 | |
| Domain | Trypsin_dom | 1.65e-03 | 121 | 78 | 4 | IPR001254 | |
| Domain | CUB_dom | 1.74e-03 | 57 | 78 | 3 | IPR000859 | |
| Domain | N2O_reductase_N | 1.75e-03 | 15 | 78 | 2 | IPR011045 | |
| Domain | Peptidase_S1_PA | 1.75e-03 | 123 | 78 | 4 | IPR009003 | |
| Domain | VWD | 1.99e-03 | 16 | 78 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.99e-03 | 16 | 78 | 2 | IPR001846 | |
| Domain | VWFD | 1.99e-03 | 16 | 78 | 2 | PS51233 | |
| Domain | VWD | 1.99e-03 | 16 | 78 | 2 | PF00094 | |
| Domain | ConA-like_dom | 2.23e-03 | 219 | 78 | 5 | IPR013320 | |
| Domain | VWC_out | 2.81e-03 | 19 | 78 | 2 | SM00215 | |
| Domain | EF_HAND_2 | 2.81e-03 | 231 | 78 | 5 | PS50222 | |
| Domain | EF_hand_dom | 2.86e-03 | 232 | 78 | 5 | IPR002048 | |
| Domain | - | 3.53e-03 | 73 | 78 | 3 | 2.60.120.260 | |
| Domain | - | 3.67e-03 | 74 | 78 | 3 | 3.40.50.410 | |
| Domain | Kazal_1 | 3.77e-03 | 22 | 78 | 2 | PF00050 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.39e-05 | 258 | 54 | 7 | MM14572 | |
| Pubmed | Skin wound healing in MMP2-deficient and MMP2 / plasminogen double-deficient mice. | 1.22e-08 | 3 | 81 | 3 | 20163454 | |
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 16147977 | ||
| Pubmed | 4.23e-07 | 7 | 81 | 3 | 15545316 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.91e-06 | 248 | 81 | 7 | 24006456 | |
| Pubmed | Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. | 2.11e-06 | 39 | 81 | 4 | 19010793 | |
| Pubmed | Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice. | 5.36e-06 | 2 | 81 | 2 | 10634603 | |
| Pubmed | Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis. | 5.36e-06 | 2 | 81 | 2 | 23943648 | |
| Pubmed | Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. | 5.36e-06 | 2 | 81 | 2 | 7705657 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23041318 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 19752236 | ||
| Pubmed | SORCS1 and SORCS3 control energy balance and orexigenic peptide production. | 5.36e-06 | 2 | 81 | 2 | 29440124 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 6216475 | ||
| Pubmed | Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. | 5.36e-06 | 2 | 81 | 2 | 20440070 | |
| Pubmed | A central role for plasminogen in the inflammatory response to biomaterials. | 5.36e-06 | 2 | 81 | 2 | 15456492 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 25409527 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 8704243 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23702659 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 21693047 | ||
| Pubmed | Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. | 5.36e-06 | 2 | 81 | 2 | 22079981 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 26807827 | ||
| Pubmed | Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. | 5.36e-06 | 2 | 81 | 2 | 9490683 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 16481742 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 18983515 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34378815 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11848464 | ||
| Pubmed | Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. | 5.36e-06 | 2 | 81 | 2 | 7586361 | |
| Pubmed | Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function. | 5.36e-06 | 2 | 81 | 2 | 21239499 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 10642175 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12225871 | ||
| Pubmed | Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. | 5.36e-06 | 2 | 81 | 2 | 37971174 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 9884337 | ||
| Pubmed | Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient Mice. | 5.36e-06 | 2 | 81 | 2 | 26473342 | |
| Pubmed | Peptides targeting the PDZ domain of PTPN4 are efficient inducers of glioblastoma cell death. | 5.36e-06 | 2 | 81 | 2 | 22000519 | |
| Pubmed | Selection of mutant µplasmin for amyloid-β cleavage in vivo. | 5.36e-06 | 2 | 81 | 2 | 32694536 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 16103174 | ||
| Pubmed | Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. | 5.36e-06 | 2 | 81 | 2 | 24408017 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 21300353 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11306011 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12149246 | ||
| Pubmed | Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis. | 5.36e-06 | 2 | 81 | 2 | 18311818 | |
| Pubmed | Localization of plasminogen in mouse hippocampus, cerebral cortex, and hypothalamus. | 5.36e-06 | 2 | 81 | 2 | 21190118 | |
| Pubmed | A physiological function for apolipoprotein(a): a natural regulator of the inflammatory response. | 5.36e-06 | 2 | 81 | 2 | 18997104 | |
| Pubmed | Growth and behavioral development in plasminogen gene-targeted mice. | 5.36e-06 | 2 | 81 | 2 | 10885855 | |
| Pubmed | Cellular density regulation of plasminogen gene expression in mouse hepatocytes. | 5.36e-06 | 2 | 81 | 2 | 12559391 | |
| Pubmed | Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. | 5.36e-06 | 2 | 81 | 2 | 15333838 | |
| Pubmed | Apo(a) promotes thrombosis in a vascular injury model by a mechanism independent of plasminogen. | 5.36e-06 | 2 | 81 | 2 | 16150044 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11916082 | ||
| Pubmed | Delayed invasion of the kidney and brain by Borrelia crocidurae in plasminogen-deficient mice. | 5.36e-06 | 2 | 81 | 2 | 11500461 | |
| Pubmed | Role of plasminogen activation in neuronal organization and survival. | 5.36e-06 | 2 | 81 | 2 | 19683575 | |
| Pubmed | Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. | 5.36e-06 | 2 | 81 | 2 | 23555246 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 18685433 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 31462325 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 31690812 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 30254165 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 38328826 | ||
| Pubmed | Reduced transplant arteriosclerosis in plasminogen-deficient mice. | 5.36e-06 | 2 | 81 | 2 | 9819364 | |
| Pubmed | Complement factor H is expressed in adipose tissue in association with insulin resistance. | 5.36e-06 | 2 | 81 | 2 | 19833879 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 31150793 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12083480 | ||
| Pubmed | Polymorphonuclear leukocyte phagocytic function increases in plasminogen knockout mice. | 5.36e-06 | 2 | 81 | 2 | 18420257 | |
| Pubmed | Plasminogen alleles influence susceptibility to invasive aspergillosis. | 5.36e-06 | 2 | 81 | 2 | 18566672 | |
| Pubmed | The generation and characterization of mice expressing a plasmin-inactivating active site mutation. | 5.36e-06 | 2 | 81 | 2 | 20653841 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12428098 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24732409 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24876560 | ||
| Pubmed | Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice. | 5.36e-06 | 2 | 81 | 2 | 24574269 | |
| Pubmed | Spontaneous development of otitis media in plasminogen-deficient mice. | 5.36e-06 | 2 | 81 | 2 | 16956791 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 1543918 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17267741 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 29990619 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17293777 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23456978 | ||
| Pubmed | Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. | 5.36e-06 | 2 | 81 | 2 | 10854210 | |
| Pubmed | Gender affects skin wound healing in plasminogen deficient mice. | 5.36e-06 | 2 | 81 | 2 | 23527289 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 9770530 | ||
| Pubmed | A genetic association study of CSMD1 and CSMD2 with cognitive function. | 5.36e-06 | 2 | 81 | 2 | 27890662 | |
| Pubmed | Plasminogen activation is required for the development of radiation-induced dermatitis. | 5.36e-06 | 2 | 81 | 2 | 30323258 | |
| Pubmed | Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer. | 5.36e-06 | 2 | 81 | 2 | 17330845 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 10816371 | ||
| Pubmed | Plasminogen is a critical regulator of cutaneous wound healing. | 5.36e-06 | 2 | 81 | 2 | 26791370 | |
| Pubmed | Identification and characterization of SorCS, a third member of a novel receptor family. | 5.36e-06 | 2 | 81 | 2 | 10600506 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 7525077 | ||
| Pubmed | The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | 5.36e-06 | 2 | 81 | 2 | 21439553 | |
| Pubmed | Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. | 5.36e-06 | 2 | 81 | 2 | 16052596 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17122079 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15737740 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 22056679 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 18039665 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 9671388 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 27241480 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 27319402 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 26080028 | ||
| Pubmed | Unaltered prion protein cleavage in plasminogen-deficient mice. | 5.36e-06 | 2 | 81 | 2 | 16543819 | |
| Pubmed | Association of CFH and CFB gene polymorphisms with retinopathy in type 2 diabetic patients. | 5.36e-06 | 2 | 81 | 2 | 23864767 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34423816 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12167431 | ||
| Pubmed | Impaired wound healing in mice with a disrupted plasminogen gene. | 5.36e-06 | 2 | 81 | 2 | 8612226 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 10537128 | ||
| Pubmed | Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis. | 5.36e-06 | 2 | 81 | 2 | 9242524 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 6.78e-06 | 1070 | 81 | 12 | 23533145 | |
| Interaction | GNG8 interactions | 6.51e-07 | 125 | 80 | 7 | int:GNG8 | |
| Interaction | SLURP1 interactions | 1.69e-06 | 144 | 80 | 7 | int:SLURP1 | |
| Interaction | EDDM3A interactions | 1.38e-05 | 37 | 80 | 4 | int:EDDM3A | |
| Interaction | PHF11 interactions | 1.76e-05 | 137 | 80 | 6 | int:PHF11 | |
| Interaction | DEFA1 interactions | 4.87e-05 | 100 | 80 | 5 | int:DEFA1 | |
| Cytoband | 10q23-q25 | 1.84e-05 | 4 | 81 | 2 | 10q23-q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q26 | 3.63e-04 | 16 | 81 | 2 | chr6q26 | |
| Cytoband | 6q26 | 4.62e-04 | 18 | 81 | 2 | 6q26 | |
| Cytoband | 18q12.1 | 9.72e-04 | 26 | 81 | 2 | 18q12.1 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.15e-08 | 57 | 56 | 6 | 1179 | |
| GeneFamily | Desmosomal cadherins | 1.96e-04 | 7 | 56 | 2 | 1188 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 1.64e-05 | 102 | 81 | 5 | MM1064 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_UP | 3.59e-05 | 199 | 81 | 6 | M9531 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP | 3.69e-05 | 200 | 81 | 6 | M3407 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_DN | 3.69e-05 | 200 | 81 | 6 | M9535 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.07e-06 | 455 | 80 | 11 | GSM777055_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.36e-06 | 466 | 80 | 11 | GSM777050_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 5.97e-05 | 357 | 80 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.72e-05 | 377 | 80 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | CFH IGSF10 BMP1 PTPN4 DSC2 CASP6 MMP2 SMOC1 PCMTD1 RYR2 AKAP7 | 1.00e-04 | 740 | 80 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#4_top-relative-expression-ranked_200 | 1.12e-04 | 25 | 80 | 3 | gudmap_developingKidney_e15.5_early proxim tubul_200_k4 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | BLVRB PCSK5 SRPX2 MATN3 SYNGR2 LTBP2 MMP2 PLG OCLN CFB AKAP7 | 1.28e-04 | 761 | 80 | 11 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | DSC2 DSC3 PCDHB12 ZFHX3 SLC2A13 PLG CTNND2 PCMTD1 ZFAND4 IGSF3 SORCS1 | 1.41e-04 | 769 | 80 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 9.33e-09 | 146 | 81 | 7 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|World / Lineage and Cell class | 4.95e-08 | 186 | 81 | 7 | 6ca8ce7ced91d6308b7c056032ffec1b37c974bf | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.93e-08 | 191 | 81 | 7 | 2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.15e-08 | 192 | 81 | 7 | 011634a24b0c61d9b463fe755502edbc5cd70b7a | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-08 | 193 | 81 | 7 | 160691b671710be10220803d788c2c961c236af1 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 6.60e-08 | 194 | 81 | 7 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.98e-07 | 155 | 81 | 6 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 4.62e-07 | 159 | 81 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-07 | 166 | 81 | 6 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.16e-07 | 167 | 81 | 6 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.38e-07 | 168 | 81 | 6 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 6.60e-07 | 169 | 81 | 6 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.60e-07 | 169 | 81 | 6 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.08e-07 | 171 | 81 | 6 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.32e-07 | 172 | 81 | 6 | df3800bcd9777d02900eba0cfc26ab73de8a1d95 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.32e-07 | 172 | 81 | 6 | 7e1a7700a4c2b1d100da1d6e475e73498ebb605a | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.94e-07 | 178 | 81 | 6 | 86f1741636ed3e85bb4a65f84949b718fc38c290 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.54e-07 | 180 | 81 | 6 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-07 | 181 | 81 | 6 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-07 | 181 | 81 | 6 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-07 | 181 | 81 | 6 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 9.86e-07 | 181 | 81 | 6 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-06 | 183 | 81 | 6 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 183 | 81 | 6 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.08e-06 | 184 | 81 | 6 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.12e-06 | 185 | 81 | 6 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-06 | 186 | 81 | 6 | 4e983de6d2515082f9e555f4f949cec84281c140 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 187 | 81 | 6 | 0f90bce2087aecfdbb377e6f46c6e468efbb6e28 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 187 | 81 | 6 | 76c957b2976d38adb45e07bcf96c689442e1fc20 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 187 | 81 | 6 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 187 | 81 | 6 | 90a1078b0303799fba5d2ca4fa12076fd75b78b1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 187 | 81 | 6 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.19e-06 | 187 | 81 | 6 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-06 | 188 | 81 | 6 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-06 | 188 | 81 | 6 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 189 | 81 | 6 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 189 | 81 | 6 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.27e-06 | 189 | 81 | 6 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.27e-06 | 103 | 81 | 5 | 39d8cfb899ca88c72ebe021d66cc21ae2eb6a1cc | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.27e-06 | 103 | 81 | 5 | 01a7baaa0c3903bd00e37717856d2c1ac21bf2c8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-06 | 190 | 81 | 6 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.31e-06 | 190 | 81 | 6 | 07215e8f292cb54c670037aaf28393cddbe5548c | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.35e-06 | 191 | 81 | 6 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.35e-06 | 191 | 81 | 6 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 192 | 81 | 6 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 192 | 81 | 6 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-06 | 192 | 81 | 6 | 0e7e55505bd5454d7cf952a63fdcb46ec76f1973 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 192 | 81 | 6 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 192 | 81 | 6 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-06 | 192 | 81 | 6 | 1b228f0929b505de82a39bf64c837887b0e56701 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 192 | 81 | 6 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-06 | 193 | 81 | 6 | 92048d2e9e43513e6185e09553be3ee47d7e5207 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-06 | 193 | 81 | 6 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-06 | 193 | 81 | 6 | e27885a9e1a2a3e165c5366d4cfcda05c5454483 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-06 | 193 | 81 | 6 | 025836c5c5a711e477c326559e618e47cae42d11 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.43e-06 | 193 | 81 | 6 | 48ce11778252ae2ef902b30816061b59a3c81695 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-06 | 193 | 81 | 6 | ac088c8f27b5b1888610e461ff45870ca60da886 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-06 | 193 | 81 | 6 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-06 | 193 | 81 | 6 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.48e-06 | 194 | 81 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.48e-06 | 194 | 81 | 6 | c9e589fe7df6a9b377654581a2aebb607cbb03b9 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 195 | 81 | 6 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 195 | 81 | 6 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 195 | 81 | 6 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.54e-06 | 107 | 81 | 5 | d446ffbe93cd49669f1cf91411aae07cc15d9e2a | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.54e-06 | 107 | 81 | 5 | 5c9e745d0b08a4aa1f3a93f9cc094fac57061a30 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 196 | 81 | 6 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 196 | 81 | 6 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.57e-06 | 196 | 81 | 6 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 1.57e-06 | 196 | 81 | 6 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-06 | 196 | 81 | 6 | 889c9fed857f64664ca1f47fcec9fecb15ed103c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-06 | 196 | 81 | 6 | ed818de15f84f7f28bd06fd69d7876710da232a0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.61e-06 | 197 | 81 | 6 | e567f91fa398fd306d025dcfe89bd50a60216537 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.61e-06 | 197 | 81 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | mLN-(2)_B_cell-(20)_B_cell_IgA_Plasma|mLN / shred on region, Cell_type, and subtype | 1.61e-06 | 197 | 81 | 6 | a39b384ee9824a08c3b544a9c3c7f0f95f08d6a7 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.61e-06 | 197 | 81 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | mLN-B_cell-B_cell_IgA_Plasma|mLN / Region, Cell class and subclass | 1.61e-06 | 197 | 81 | 6 | 20822fce311326765b71337ce501ba44ea14f58f | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-06 | 198 | 81 | 6 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 1.66e-06 | 198 | 81 | 6 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.66e-06 | 198 | 81 | 6 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-06 | 198 | 81 | 6 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.71e-06 | 199 | 81 | 6 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Basal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.71e-06 | 199 | 81 | 6 | 6a274a5db02c55bbf31d602b9d5c8394241acdca | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-06 | 199 | 81 | 6 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-06 | 199 | 81 | 6 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-06 | 199 | 81 | 6 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 81 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 81 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-06 | 200 | 81 | 6 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.76e-06 | 200 | 81 | 6 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 81 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.76e-06 | 200 | 81 | 6 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 81 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-06 | 200 | 81 | 6 | c239e6f5d23caa9a59b83e9b352b2d6a691dcb28 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 81 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-06 | 200 | 81 | 6 | 061ba851f941c616ddb462512e826c412881c3ce | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 81 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.76e-06 | 200 | 81 | 6 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.65e-06 | 134 | 81 | 5 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.56e-06 | 139 | 81 | 5 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| Computational | Genes in the cancer module 107. | 4.50e-05 | 79 | 54 | 5 | MODULE_107 | |
| Computational | Catabolic peptidases. | 7.98e-05 | 89 | 54 | 5 | MODULE_209 | |
| Computational | Genes in the cancer module 172. | 1.14e-04 | 96 | 54 | 5 | MODULE_172 | |
| Computational | MMPs. | 1.50e-04 | 21 | 54 | 3 | MODULE_562 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | CFH BLVRB BMP1 FAT2 FCGBP WDR7 HPR PEPD UMOD MMP2 PLG OCLN CFB | 1.90e-04 | 835 | 54 | 13 | MODULE_88 |
| Computational | Genes in the cancer module 55. | 7.03e-04 | 832 | 54 | 12 | MODULE_55 | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; PC3; HT_HG-U133A | 5.88e-06 | 196 | 80 | 7 | 3776_DN | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; MCF7; HT_HG-U133A | 6.28e-06 | 198 | 80 | 7 | 1537_DN | |
| Drug | Fonofos | FCGBP DSC3 LPA MATN3 FSTL5 ROR1 CNTNAP2 ZFHX3 SLC2A13 CTNND2 CFB RYR2 | 7.05e-06 | 714 | 80 | 12 | ctd:D004397 |
| Drug | terbufos | FCGBP DSC3 LPA MATN3 FSTL5 ROR1 CNTNAP2 ZFHX3 SLC2A13 CTNND2 CFB RYR2 | 8.12e-06 | 724 | 80 | 12 | ctd:C012568 |
| Drug | Vanadates | DPP7 SRPX2 ARSB DSC2 DSC3 ROR1 SYNGR2 RAVER2 PCDHB12 ZFHX3 LTBP2 ABCG2 MMP2 PCMTD1 WDR17 ZFAND4 | 9.97e-06 | 1302 | 80 | 16 | ctd:D014638 |
| Drug | albendazole sulfoxide | 1.22e-05 | 2 | 80 | 2 | ctd:C027186 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 9.86e-07 | 8 | 78 | 3 | DOID:0060308 (implicated_via_orthology) | |
| Disease | monokine induced by gamma interferon measurement | 1.11e-05 | 52 | 78 | 4 | EFO_0008236 | |
| Disease | Hepatomegaly | 1.29e-05 | 54 | 78 | 4 | C0019209 | |
| Disease | complement C3D fragment measurement | 2.07e-05 | 3 | 78 | 2 | EFO_0020277 | |
| Disease | Epilepsy, Rolandic | 2.07e-05 | 3 | 78 | 2 | C0376532 | |
| Disease | cysteine and glycine-rich protein 2 measurement | 2.07e-05 | 3 | 78 | 2 | EFO_0802444 | |
| Disease | neurogenic locus notch homolog protein 2 measurement | 2.07e-05 | 3 | 78 | 2 | EFO_0020599 | |
| Disease | Benign Rolandic Epilepsy | 2.07e-05 | 3 | 78 | 2 | C2363129 | |
| Disease | sorting nexin-7 measurement | 4.12e-05 | 4 | 78 | 2 | EFO_0803094 | |
| Disease | uromodulin measurement | 4.42e-05 | 26 | 78 | 3 | EFO_0021778 | |
| Disease | macular degeneration (is_implicated_in) | 4.97e-05 | 27 | 78 | 3 | DOID:4448 (is_implicated_in) | |
| Disease | Age related macular degeneration | 6.85e-05 | 30 | 78 | 3 | C0242383 | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 6.86e-05 | 5 | 78 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (implicated_via_orthology) | 6.86e-05 | 5 | 78 | 2 | DOID:0050431 (implicated_via_orthology) | |
| Disease | desmocollin-2 measurement | 6.86e-05 | 5 | 78 | 2 | EFO_0021936 | |
| Disease | plasma plasminogen measurement | 6.86e-05 | 5 | 78 | 2 | EFO_0006309 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 6.86e-05 | 5 | 78 | 2 | DOID:3030 (is_marker_for) | |
| Disease | synaptotagmin-like protein 4 measurement | 6.86e-05 | 5 | 78 | 2 | EFO_0802109 | |
| Disease | interleukin-10 receptor subunit beta measurement | 6.86e-05 | 5 | 78 | 2 | EFO_0020489 | |
| Disease | hyperuricemia | 9.16e-05 | 33 | 78 | 3 | EFO_0009104 | |
| Disease | aurora kinase B measurement | 1.03e-04 | 6 | 78 | 2 | EFO_0020169 | |
| Disease | DNA-binding protein SATB2 measurement | 1.03e-04 | 6 | 78 | 2 | EFO_0802484 | |
| Disease | thymidine kinase, cytosolic measurement | 1.03e-04 | 6 | 78 | 2 | EFO_0020773 | |
| Disease | NKG2-E type II integral membrane protein measurement | 1.03e-04 | 6 | 78 | 2 | EFO_0801842 | |
| Disease | transcription factor AP-1 measurement | 1.03e-04 | 6 | 78 | 2 | EFO_0021909 | |
| Disease | CCAAT/enhancer-binding protein beta measurement | 1.03e-04 | 6 | 78 | 2 | EFO_0021905 | |
| Disease | angiostatin measurement | 1.03e-04 | 6 | 78 | 2 | EFO_0008024 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.41e-04 | 99 | 78 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | triglyceride measurement, alcohol drinking | 1.41e-04 | 99 | 78 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | mast/stem cell growth factor receptor kit measurement | 1.44e-04 | 7 | 78 | 2 | EFO_0020554 | |
| Disease | Glomerulonephritis, Membranoproliferative | 1.44e-04 | 7 | 78 | 2 | C0017662 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 1.44e-04 | 7 | 78 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 1.52e-04 | 101 | 78 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.58e-04 | 102 | 78 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 1.64e-04 | 40 | 78 | 3 | EFO_0004746 | |
| Disease | clinical treatment | 1.76e-04 | 41 | 78 | 3 | EFO_0007056 | |
| Disease | anterior uveitis (is_implicated_in) | 1.91e-04 | 8 | 78 | 2 | DOID:1407 (is_implicated_in) | |
| Disease | PH and SEC7 domain-containing protein 1 measurement | 1.91e-04 | 8 | 78 | 2 | EFO_0803302 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 1.91e-04 | 8 | 78 | 2 | DOID:0080301 (is_implicated_in) | |
| Disease | complement C1q and tumor necrosis factor-related protein 9A measurement | 2.45e-04 | 9 | 78 | 2 | EFO_0803293 | |
| Disease | Atypical hemolytic-uremic syndrome | 2.45e-04 | 9 | 78 | 2 | cv:C2931788 | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 2.45e-04 | 9 | 78 | 2 | EFO_0009824 | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 2.45e-04 | 9 | 78 | 2 | EFO_0010613 | |
| Disease | C3 glomerulopathy | 2.45e-04 | 9 | 78 | 2 | C4087273 | |
| Disease | Hemolytic-uremic syndrome | 2.45e-04 | 9 | 78 | 2 | cv:C0019061 | |
| Disease | complement factor B measurement | 2.45e-04 | 9 | 78 | 2 | EFO_0008096 | |
| Disease | HLA class II histocompatibility antigen, DQ alpha 2 chain measurement | 2.45e-04 | 9 | 78 | 2 | EFO_0801686 | |
| Disease | glycoprotein measurement | 2.85e-04 | 119 | 78 | 4 | EFO_0004555 | |
| Disease | cholestasis (biomarker_via_orthology) | 3.00e-04 | 49 | 78 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | Atypical Hemolytic Uremic Syndrome | 3.06e-04 | 10 | 78 | 2 | C2931788 | |
| Disease | non-receptor tyrosine-protein kinase TYK2 measurement | 3.06e-04 | 10 | 78 | 2 | EFO_0008251 | |
| Disease | hydroxyproline measurement | 3.06e-04 | 10 | 78 | 2 | EFO_0010498 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 3.06e-04 | 10 | 78 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | interleukin-37 measurement | 3.06e-04 | 10 | 78 | 2 | EFO_0020506 | |
| Disease | diabetic retinopathy (is_implicated_in) | 3.18e-04 | 50 | 78 | 3 | DOID:8947 (is_implicated_in) | |
| Disease | Semantic-Pragmatic Disorder | 3.74e-04 | 11 | 78 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 3.74e-04 | 11 | 78 | 2 | C0751257 | |
| Disease | Language Delay | 3.74e-04 | 11 | 78 | 2 | C0023012 | |
| Disease | Language Development Disorders | 3.74e-04 | 11 | 78 | 2 | C0023014 | |
| Disease | vascular dementia (is_marker_for) | 3.74e-04 | 11 | 78 | 2 | DOID:8725 (is_marker_for) | |
| Disease | Marfan Syndrome | 3.74e-04 | 11 | 78 | 2 | C0024796 | |
| Disease | Speech Delay | 3.74e-04 | 11 | 78 | 2 | C0241210 | |
| Disease | bitter alcoholic beverage consumption measurement | 4.35e-04 | 133 | 78 | 4 | EFO_0010092 | |
| Disease | triglycerides in LDL measurement | 4.45e-04 | 56 | 78 | 3 | EFO_0022320 | |
| Disease | Malignant neoplasm of breast | 5.22e-04 | 1074 | 78 | 10 | C0006142 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 5.28e-04 | 13 | 78 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | triglycerides in medium LDL measurement | 6.01e-04 | 62 | 78 | 3 | EFO_0022322 | |
| Disease | wet macular degeneration | 6.15e-04 | 14 | 78 | 2 | EFO_0004683 | |
| Disease | C-C motif chemokine 19 measurement | 6.15e-04 | 14 | 78 | 2 | EFO_0008047 | |
| Disease | susceptibility to hepatitis B infection measurement | 6.59e-04 | 64 | 78 | 3 | EFO_0008405 | |
| Disease | diabetic nephropathy | 6.83e-04 | 150 | 78 | 4 | EFO_0000401 | |
| Disease | response to statin, LDL cholesterol change measurement | 7.08e-04 | 15 | 78 | 2 | EFO_0007804, GO_0036273 | |
| Disease | Drug-Induced Liver Disease | 7.11e-04 | 404 | 78 | 6 | C0860207 | |
| Disease | Chemical and Drug Induced Liver Injury | 7.11e-04 | 404 | 78 | 6 | C4277682 | |
| Disease | Drug-Induced Acute Liver Injury | 7.11e-04 | 404 | 78 | 6 | C3658290 | |
| Disease | Hepatitis, Toxic | 7.11e-04 | 404 | 78 | 6 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 7.11e-04 | 404 | 78 | 6 | C4279912 | |
| Disease | Hepatitis, Drug-Induced | 7.11e-04 | 404 | 78 | 6 | C1262760 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.18e-04 | 152 | 78 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 7.21e-04 | 66 | 78 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | anti-anoctamin 2 antibody measurement | 9.14e-04 | 17 | 78 | 2 | EFO_0010150 | |
| Disease | major depressive disorder (is_implicated_in) | 9.14e-04 | 17 | 78 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | Age-related macular degeneration | 1.03e-03 | 18 | 78 | 2 | cv:C0242383 | |
| Disease | interleukin 18 measurement | 1.09e-03 | 76 | 78 | 3 | EFO_0004581 | |
| Disease | squamous cell carcinoma (is_marker_for) | 1.15e-03 | 19 | 78 | 2 | DOID:1749 (is_marker_for) | |
| Disease | schizophrenia (is_implicated_in) | 1.17e-03 | 78 | 78 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.20e-03 | 447 | 78 | 6 | EFO_0000694, MONDO_0100096 | |
| Disease | unipolar depression | 1.26e-03 | 1206 | 78 | 10 | EFO_0003761 | |
| Disease | atherosclerosis (biomarker_via_orthology) | 1.27e-03 | 20 | 78 | 2 | DOID:1936 (biomarker_via_orthology) | |
| Disease | glaucoma (is_marker_for) | 1.27e-03 | 20 | 78 | 2 | DOID:1686 (is_marker_for) | |
| Disease | Epilepsy, Cryptogenic | 1.35e-03 | 82 | 78 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 1.35e-03 | 82 | 78 | 3 | C0751111 | |
| Disease | Aura | 1.35e-03 | 82 | 78 | 3 | C0236018 | |
| Disease | COVID-19 (is_implicated_in) | 1.40e-03 | 21 | 78 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | gastric ulcer (biomarker_via_orthology) | 1.40e-03 | 21 | 78 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | Deep Vein Thrombosis | 1.40e-03 | 21 | 78 | 2 | C0149871 | |
| Disease | haptoglobin measurement | 1.40e-03 | 21 | 78 | 2 | EFO_0004640 | |
| Disease | Venous Thrombosis | 1.40e-03 | 21 | 78 | 2 | C0042487 | |
| Disease | facial morphology measurement | 1.48e-03 | 466 | 78 | 6 | EFO_0007841 | |
| Disease | Splenomegaly | 1.54e-03 | 22 | 78 | 2 | C0038002 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYIEFHCGVDGYVDN | 121 | Q14507 | |
| VSAHGNFYEGDCYVI | 31 | O75366 | |
| TGYTGETCHSSLYEQ | 576 | Q9BZ76 | |
| TYGAVVHYSCRGSES | 2876 | Q96PZ7 | |
| TYYCHGGYEVEGTST | 1581 | Q7Z408 | |
| DTGHQLLDYCSGYVD | 1111 | P42684 | |
| SNGYYHCESSIVIGE | 271 | Q9P0M2 | |
| QEALGYFESAGYHCE | 271 | Q9UNQ0 | |
| LRCLTTDEYDGHSTY | 186 | P30043 | |
| YEYSERGDAVCTESG | 241 | P08603 | |
| TLDYECHDGYESNTG | 531 | P08603 | |
| GYQCSGNDEHTSYGE | 31 | Q9NZJ0 | |
| DYTSTSEEEYGSRHG | 1256 | Q9Y4F5 | |
| DQSIECVDRAGYHYT | 331 | Q9NUG4 | |
| RSESCHTDGTYAYDA | 356 | Q9NUG4 | |
| DSCAYDYLEVRDGHS | 486 | P13497 | |
| RKTDYECTGSNATYH | 1086 | Q9UQB3 | |
| GGHTEVDNCRYTYSE | 811 | Q02487 | |
| SYDSCTTEGRTDGYR | 301 | P08253 | |
| VECVDQHSQGTGAYY | 666 | Q9HCJ3 | |
| QSYHYEVCLTGDSGA | 746 | Q9Y5E4 | |
| ELESLFEHYCYSRGG | 221 | P12955 | |
| DHYETDYTTGGESCD | 396 | Q16625 | |
| YGCYQVTCHSEEGNT | 776 | P29074 | |
| GDRASGYHYNALTCE | 141 | Q96RI1 | |
| EISFHCYDGYTLRGS | 126 | P00751 | |
| LYHEGYACTSIHGDR | 461 | O00571 | |
| QREIQEGAYSGSCYH | 886 | Q96RG2 | |
| HEHTDIQEYIGCYTS | 1111 | Q9NU22 | |
| DRTGSHHCECYEGYT | 366 | O15232 | |
| TYCRHNYGVGESFTV | 106 | Q30154 | |
| ADQYDCITHYEGSTC | 246 | P00739 | |
| SVAEGYYSHRETVNG | 211 | P55212 | |
| GSLYSEDHDGYCASV | 601 | Q5SYE7 | |
| DSHQYDRIYCGAGVQ | 156 | Q96MG8 | |
| TSCGADNYGREHFLY | 951 | Q92824 | |
| TATDRDHGENGYVTY | 481 | Q9NYQ8 | |
| GTEARCYTNHALSYD | 71 | Q9Y2C4 | |
| ATCAVYGDGHYLTFD | 901 | P98088 | |
| SQSYHYEVCVTGGSR | 746 | Q9Y5F1 | |
| VTTTHVGNYTCYADG | 311 | Q8N475 | |
| LYEDRGFQGRHYECS | 6 | P07320 | |
| TGVYHCISSNYDDAD | 546 | Q6WRI0 | |
| RAEVSDSGSYYCHVE | 771 | O75054 | |
| GGHTEVDNCRYTYSE | 806 | Q14574 | |
| DGYENIIVHTYSCDT | 546 | A8K855 | |
| TLDGRVYDLHGSCSY | 4866 | Q9Y6R7 | |
| CVYKQYDRDHSGSLG | 156 | Q96L46 | |
| VQDCYHGDGQSYRGS | 1271 | P08519 | |
| DCYHGDGRSYRGISS | 1501 | P08519 | |
| TNTEGSYHCECDQGY | 946 | Q14767 | |
| SDAGRYYCAADNVHS | 351 | Q96P31 | |
| GSEDYYSHERCTLID | 171 | P15848 | |
| GYDGHTFLDSVECYD | 571 | Q14145 | |
| DETGYSGATCHNSIY | 581 | Q9UHC6 | |
| LERYHGYSCDCSNTA | 981 | Q9UHC6 | |
| HDNCIYIYGVSDNGR | 646 | O00423 | |
| DQLGGSCRTHYGYSS | 371 | P16444 | |
| YGDSVCYIQHVDTGL | 356 | Q92736 | |
| GLVYNASGSEHCYDI | 311 | Q9UHL4 | |
| TGYTGETCHSSLYEQ | 576 | Q96NU0 | |
| CGTSDSDEGRYIEYI | 616 | Q96QE2 | |
| SCGYYHSAFVTTDGE | 196 | Q92834 | |
| TREEECHFYAGGQVY | 46 | Q13162 | |
| EHAGRYRCYYGSDTA | 91 | Q8NHL6 | |
| EECAITYSNSHGSYD | 476 | Q6P3W6 | |
| DFECDYGYERHGESQ | 751 | Q9UPU3 | |
| DHVCNASDNTGRYAY | 361 | Q9BVL4 | |
| DTVYDHGADVYGLTC | 646 | Q8IZU2 | |
| DCYHGDGQSYRGTSS | 376 | P00747 | |
| HKCYNSTGVDYRGTV | 311 | Q01973 | |
| DGSFTQVQCHTYTGY | 121 | Q9H4F8 | |
| STEYGEGYACDTDLR | 186 | P07911 | |
| DYSCSSGYHLEGDRS | 146 | O60687 | |
| CAVQDYTYRGSISGH | 66 | Q8NCR6 | |
| QVITGGHYDVDCYVE | 56 | Q9Y3Q3 | |
| EGLHYTEVCGYDIAS | 606 | P29144 | |
| SCIYGEGYSNAHESK | 41 | O43760 | |
| YEECGKITHSGEESY | 321 | Q9NSJ1 | |
| ETHGCTYDYKSAGRR | 696 | Q86XD8 | |
| ADFDCDYGYERHSNG | 726 | Q8WY21 | |
| YEDGRGSRHAYSTQS | 51 | Q5SRN2 | |
| SDDYLVVGCSDGSVY | 571 | Q9Y4E6 | |
| EAYEEAALRCYGHEG | 641 | C9JLR9 | |
| QHESGVEGESCYYHC | 1076 | Q15911 | |
| YCSRDSRGHNDVYIS | 1411 | Q12879 |